|
시장보고서
상품코드
1619037
유방 영상 진단 기술 시장 규모, 점유율, 성장 분석 : 기술별, 제품별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)Breast Imaging Technologies Market Size, Share, Growth Analysis, By Technology, By Product, By End Use, By Region - Industry Forecast 2024-2031 |
||||||
세계 유방 영상 진단 기술 시장 규모는 2022년 47억 달러로 평가되며, 예측 기간(2024-2031년) 동안 8.5%의 CAGR로 2023년 51억 달러에서 2031년 97억 9,000만 달러로 성장할 것으로 예상됩니다.
2023년 10월 현재, 유방암 및 관련 질환의 조기 발견 및 진단에 필수적인 유방 영상 진단은 진단 방사선학의 중요한 하위 분야로 계속 부상하고 있습니다. 주요 기술로는 유방촬영술, 유방 MRI, 초음파 검사 등이 있으며, 유방 조직의 이상 유무를 면밀히 분석합니다. 그 중에서도 유방촬영술은 저선량 엑스레이를 이용해 증상이 나타나기 전 가장 초기에 암을 발견할 수 있는 가장 보편적인 방법입니다. 또한 CT(컴퓨터 단층촬영), PET(양전자방사선 단층 촬영) 등 첨단 영상 진단 기술도 보다 종합적인 암 평가를 위해 도입되고 있습니다. 유방 건강에 대한 인식이 높아짐에 따라 유방 영상 진단 기술 시장은 확대되고 있으며, 환자의 예후를 개선하기 위한 조기 발견의 중요성이 강조되고 있습니다.
Global Breast Imaging Technologies Market size was valued at USD 4.70 billion in 2022 and is poised to grow from USD 5.10 billion in 2023 to USD 9.79 billion by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).
As of October 2023, breast imaging continues to emerge as a vital subfield within diagnostic radiology, crucial for the early detection and diagnosis of breast cancer and related diseases. Key technologies employed include mammograms, breast MRIs, and ultrasounds, which meticulously analyze breast tissues for any anomalies. Among these, mammography remains the most prevalent method, utilizing low-dose X-rays to identify cancer at its earliest stages, even prior to symptom manifestation. Additionally, advanced imaging techniques like computed tomography (CT) and positron emission tomography (PET) are incorporated for more comprehensive cancer assessments. With growing awareness of breast health, the market for breast imaging technologies is poised for expansion, emphasizing the importance of early detection in improving patient outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Imaging Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Breast Imaging Technologies Market Segmental Analysis
Global Breast Imaging Technologies Market is segmented by technology, product, end use and region. Based on technology, the market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. Based on product, the market is segmented into hollow breast imaging systems and software and services, accessories. Based on end use, the market is segmented into hospitals and clinics, diagnostic imaging centers, breast care centers and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Breast Imaging Technologies Market
The Global Breast Imaging Technologies market is primarily driven by the rising incidence of breast cancer among women, coupled with an increasing demand for early diagnosis and intervention. For instance, Breastcancer.org reported around 281,550 new cases of invasive breast cancer in the United States in 2021, highlighting that 1 in 8 women will face this diagnosis in their lifetime. This growing prevalence motivates the adoption of advanced breast imaging technologies for timely detection and treatment. Additionally, the expanding approvals of innovative imaging systems, such as Seno Medical's Imagio P200003, authorized by the FDA in April 2021, further propels market expansion as these advancements enhance physicians' diagnostic capabilities.
Restraints in the Global Breast Imaging Technologies Market
Global Breast Imaging Technologies must adhere to stringent safety and effectiveness standards established by regulatory bodies to ensure patient welfare. The company is obligated to invest in ongoing research and development to stay at the forefront of technological advances in breast imaging, while also focusing on training medical personnel adequately on the use of their equipment. Furthermore, they are required to maintain data privacy and security for patient information, ensuring compliance with local and international laws. Additionally, ethical marketing practices must be upheld to avoid misleading healthcare professionals and patients regarding the capabilities of their imaging technologies.
Market Trends of the Global Breast Imaging Technologies Market
A significant trend shaping the global breast imaging technologies market is the increasing integration of advanced technologies, particularly artificial intelligence (AI), which enhances diagnostic accuracy and workflow efficiency. AI algorithms assist radiologists by analyzing extensive 3D screening data, enabling quicker identification of malignancies and reducing the risk of human error. This technological advancement fosters a more precise diagnostic environment, leading to improved patient outcomes. As healthcare systems worldwide recognize the benefits of AI in breast imaging, its adoption is rapidly gaining momentum, driving innovation and investment in the sector, thereby reshaping the landscape of breast cancer detection and management.